These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 4326387

  • 21. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
    Child DF, Burke CW, Burley DM, Rees LH, Fraser TR.
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
    [Abstract] [Full Text] [Related]

  • 22. Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
    Hunter PR, Ross W, Hall R, Cook DB.
    Proc R Soc Med; 1974 Dec; 67(12 Pt 1):1225. PubMed ID: 4375290
    [No Abstract] [Full Text] [Related]

  • 23. Amino-glutethimide (elipten) in adenocortical carcinoma.
    Miranda-Zetterstrand N, Díaz-Bonet L, Pagán-Sáez H, Rosaly de Jirau W.
    Bol Asoc Med P R; 1968 Dec; 60(12):611-8. PubMed ID: 5253414
    [No Abstract] [Full Text] [Related]

  • 24. Therapeutic possibilities in Cushing's syndrome.
    Melby JC.
    N Engl J Med; 1971 Jul 29; 285(5):288-9. PubMed ID: 4326258
    [No Abstract] [Full Text] [Related]

  • 25. [Use of aminoglutethimide in a case of Cushing's syndrome due to ectopic ACTH production].
    Neri V, Schieppati G, Rondena M, Cozzi C.
    Clin Ter; 1977 Oct 31; 83(2):163-73. PubMed ID: 201424
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment of secondary hyperaldosteronism].
    Werning C, Siegenthaler W.
    Dtsch Med Wochenschr; 1969 Oct 03; 94(40):2051-3. PubMed ID: 5356332
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The relationship between cortisol and ACTH in patients with Cushing's disease following neurosurgery or pharmacotherapy.
    Kasperlik-Załuska A, Migdalska B, Jeske W, Wiśniewska-Woźniak T, Sek S.
    Endokrynol Pol; 1989 Oct 03; 40(2):63-7. PubMed ID: 2560712
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Corticosteroidogenesis inhibitors. II. A new cortico-adrenal inhibitor: amino-glutethimide (16,038Ba)].
    Philbert M, Luton JP, Mathieu de Fossey B, Bricaire H.
    Presse Med (1893); 1968 May 11; 76(23):1107-10. PubMed ID: 5657304
    [No Abstract] [Full Text] [Related]

  • 32. Lack of responsiveness to L-dopa in Cushing's disease.
    Krieger DT.
    J Clin Endocrinol Metab; 1973 Feb 11; 36(2):277-84. PubMed ID: 4345691
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Delay of hormonally induced diabetes by amino-glutethimide and metyrapone in partially pancreatectomized rats bearing transplantable pituitary tumors. Concomitant failure to prevent splanchnomegaly.
    Bates RW, Garrison MM.
    Endocrinology; 1970 Jan 11; 86(1):107-19. PubMed ID: 4311190
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Current therapeutic concepts--Cushing's syndrome.
    Kishi DT.
    J Am Pharm Assoc; 1975 May 11; 15(5):261-70. PubMed ID: 164494
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of amino-glutethimide on adrenal function in man.
    Fishman LM, Liddle GW, Island DP, Fleischer N, Küchel O.
    J Clin Endocrinol Metab; 1967 Apr 11; 27(4):481-90. PubMed ID: 4290077
    [No Abstract] [Full Text] [Related]

  • 40. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
    Ambrosi B, Gaggini M, Secchi F, Faglia G.
    Horm Metab Res; 1979 Apr 11; 11(4):318-9. PubMed ID: 222663
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.